|
[1]
|
World Health Organization. Coronavirus disease (COVID-2019) situation reports. 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. [2021-10-31].https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports |
|
[2]
|
Banerjee A, Pasea L, Harris S, Gonzalez-Izquierdo A, Torralbo A, Shallcross L, et al. Estimating excess 1-year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adults. medRxiv, 2020. http://dx.doi.org/10.1101/2020.03.22.20040287.http://dx.doi.org/10.1101/2020.03.22.20040287 |
|
[3]
|
Chan MS, van den Hout A, Pujades-Rodriguez M, Jones MM, Matthews FE, Jagger C, et al. Socio-economic inequalities in life expectancy of older adults with and without multimorbidity: a record linkage study of 1.1 million people in England. Int J Epidemiol 2019;48(4):1340-51. http://dx.doi.org/10.1093/ije/dyz052CrossRef
|
|
[4]
|
Gardner JW, Sanborn JS. Years of potential life lost (YPLL)—what does it measure?. Epidemiology 1990;1(4):322-9. http://dx.doi.org/10.1097/00001648-199007000-00012CrossRef
|
|
[5]
|
Hanlon P, Chadwick F, Shah A, Wood R, Minton J, McCartney G, et al. COVID-19–exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Res 2021;5:75. http://dx.doi.org/10.12688/wellcomeopenres.15849.3CrossRef
|
|
[6]
|
Moran PAP. The estimation of standard errors in monte carlo simulation experiments. Biometrika 1975;62(1):1-4. http://dx.doi.org/10.1093/biomet/62.1.1CrossRef
|
|
[7]
|
Chiang CL. The life table and its applications. Malabar: Robert E. Krieger Publishing Company. 1984. https://openlibrary.org/books/OL3500112M/The_life_table_and_its_applications.https://openlibrary.org/books/OL3500112M/The_life_table_and_its_applications |
|
[8]
|
Chen SQ, Jones LA, Jiang S, Jin HJ, Dong D, Chen X, et al. Difficulty and help with activities of daily living among older adults living alone during the COVID-19 pandemic: a multi-country population-based study. BMC Geriatr 2022;22(1):181. http://dx.doi.org/10.1186/s12877-022-02799-wCrossRef
|
|
[9]
|
Hale T, Angrist N, Boby T, Cameron-Blake E, Hallas L, Kira B, et al. Variation in government responses to COVID-19. Blavatnik School of Government Working Paper. 2020. https://www.bsg.ox.ac.uk/sites/default/files/2020-12/BSG-WP-2020-032-v10.pdf. [2021-10-31].https://www.bsg.ox.ac.uk/sites/default/files/2020-12/BSG-WP-2020-032-v10.pdf |
|
[10]
|
Jiang YW, Cai D, Chen DQ, Jiang S. The cost-effectiveness of conducting three versus two reverse transcription-polymerase chain reaction tests for diagnosing and discharging people with COVID-19: evidence from the epidemic in Wuhan, China. BMJ Glob Health 2020;5(7):e002690. http://dx.doi.org/10.1136/bmjgh-2020-002690CrossRef
|
|
[11]
|
Jiang YW, Cai D, Chen DQ, Jiang S, Si L, Wu J. Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios. Br J Clin Pharmacol 2021;87(11):4386-96. http://dx.doi.org/10.1111/bcp.14860CrossRef
|
|
[12]
|
Jiang YW, Chen DQ, Cai D, Yi Y, Jiang S. Effectiveness of remdesivir for the treatment of hospitalized COVID-19 persons: a network meta-analysis. J Med Virol 2021;93(2):1171-4. http://dx.doi.org/10.1002/jmv.26443CrossRef
|